SCHEMBL5456882

SCHEMBL5456882

CCOc1cccc(NC(=O)Nc2ccc(N3CCN(C(=O)Nc4ncc(F)cc4F)CC3)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.49
ALDH1A1 P00352 6/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
GLA P06280 1/20 0.48
POLB P06746 2/20 0.47
FAAH O00519 1/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
EPHX2 P34913 1/20 0.46
KIT P10721 1/20 0.46
ALOX15 P16050 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
MAPK1 P28482 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5460880 0.87 MAPT (0.49) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL5467429 0.86 MAPT (0.48) MAPTALDH1A1NPC1RAB9APOLB
SCHEMBL5459861 0.83 MAPT (0.50) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL5457909 0.83 MAPT (0.52) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL5467383 0.83 MAPT (0.56) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL5460786 0.81 MAPT (0.48) MAPTALDH1A1NPC1RAB9AGLA
SCHEMBL5460071 0.81 KMT2A (0.59) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL5454288 0.81 MEN1 (0.49) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL5459753 0.80 MAPT (0.45) MAPTALDH1A1NPSR1NPC1RAB9A
SCHEMBL5465526 0.79 GLA (0.47) MAPTALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 MAPT 758/4885ALDH1A1 731/4885NPSR1 3039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.